Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:56 PM
Study NCT ID:
NCT04042558
Status:
COMPLETED
Last Update Posted:
2025-05-31
First Post:
2019-07-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Sponsor:
Centre Francois Baclesse
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-29
First Submit QC Date:
None
Study First Post Date:
2019-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-27
Last Update Post Date:
2025-05-31
Last Update Post Date Type:
ACTUAL